Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
April 22, 2019
Mast cell-induced immunopathology in recurrent pregnancy losses
Youssef Derbala, Haidy Elazzamy, Mahmood Bilal, et al.
The Journal of Cell Biology
|
May 12, 2020
E3 ligase RFWD3 is a novel modulator of stalled fork stability in BRCA2-deficient cells
Haohui Duan, Sarah Mansour, Rachel Reed, et al.
Clinical Proteomics
|
July 29, 2023
Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus
Kevin Y C Su, John A Reynolds, Rachel Reed, et al.
Dalton Transactions (Cambridge, England : 2003)
|
September 21, 2019
The role of neutral Rh(PONOP)H, free NMe<sub>2</sub>H, boronium and ammonium salts in the dehydrocoupling of dimethylamine-borane using the cationic pincer [Rh(PONOP)(η<sup>2</sup>-H<sub>2</sub>)]<sup>+</sup> catalyst
E Anastasia K Spearing-Ewyn, Nicholas A Beattie, Annie L Colebatch, et al.
Nature Communications
|
November 18, 2014
BRCA1 haploinsufficiency for replication stress suppression in primary cells
Shailja Pathania, Sangeeta Bade, Morwenna Le Guillou, et al.
British Journal of Cancer
|
February 22, 2023
Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women
Kelechi Njoku, Andrew Pierce, Bethany Geary, et al.
Cancers
|
February 25, 2023
A Novel Blood Proteomic Signature for Prostate Cancer
Ammara Muazzam, Matt Spick, Olivier N F Cexus, et al.
Bioinformatics (Oxford, England)
|
December 3, 2019
The use of missing values in proteomic data-independent acquisition mass spectrometry to enable disease activity discrimination
Kathryn A McGurk, Arianna Dagliati, Davide Chiasserini, et al.
Frontiers in Oncology
|
August 12, 2025
Radiation-induced extracellular matrix remodelling drives prognosis and predicts radiotherapy response in muscle-invasive bladder cancer
Conrado Guerrero Quiles, Siobhan Fahy, Matej Bartak, et al.
British Journal of Haematology
|
September 14, 2020
Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)
Adam Gibb, Sarah J Pirrie, Kim Linton, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
April 22, 2019
Mast cell-induced immunopathology in recurrent pregnancy losses
Youssef Derbala, Haidy Elazzamy, Mahmood Bilal, et al.
The Journal of Cell Biology
|
May 12, 2020
E3 ligase RFWD3 is a novel modulator of stalled fork stability in BRCA2-deficient cells
Haohui Duan, Sarah Mansour, Rachel Reed, et al.
Clinical Proteomics
|
July 29, 2023
Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus
Kevin Y C Su, John A Reynolds, Rachel Reed, et al.
Dalton Transactions (Cambridge, England : 2003)
|
September 21, 2019
The role of neutral Rh(PONOP)H, free NMe<sub>2</sub>H, boronium and ammonium salts in the dehydrocoupling of dimethylamine-borane using the cationic pincer [Rh(PONOP)(η<sup>2</sup>-H<sub>2</sub>)]<sup>+</sup> catalyst
E Anastasia K Spearing-Ewyn, Nicholas A Beattie, Annie L Colebatch, et al.
Nature Communications
|
November 18, 2014
BRCA1 haploinsufficiency for replication stress suppression in primary cells
Shailja Pathania, Sangeeta Bade, Morwenna Le Guillou, et al.
British Journal of Cancer
|
February 22, 2023
Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women
Kelechi Njoku, Andrew Pierce, Bethany Geary, et al.
Cancers
|
February 25, 2023
A Novel Blood Proteomic Signature for Prostate Cancer
Ammara Muazzam, Matt Spick, Olivier N F Cexus, et al.
Bioinformatics (Oxford, England)
|
December 3, 2019
The use of missing values in proteomic data-independent acquisition mass spectrometry to enable disease activity discrimination
Kathryn A McGurk, Arianna Dagliati, Davide Chiasserini, et al.
Frontiers in Oncology
|
August 12, 2025
Radiation-induced extracellular matrix remodelling drives prognosis and predicts radiotherapy response in muscle-invasive bladder cancer
Conrado Guerrero Quiles, Siobhan Fahy, Matej Bartak, et al.
British Journal of Haematology
|
September 14, 2020
Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)
Adam Gibb, Sarah J Pirrie, Kim Linton, et al.
Page
of 8